In this article KHC A customer shops in a Kroger grocery store on July 15, 2022 in Houston, Texas. Brandon Bell | Getty Images Investors have cheered a new class of weight loss drugs for their ability to help people shed unwanted pounds, but the findings of a recent poll underscore the challenges patients face if they cease treatment. The survey by Deutsche Bank found that calorie consumption declines when a patient takes a GLP-1 medication like Novo Nordisk's Ozempic or Wegovy. However, once the medication ...